Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients.

Potharaju M, Mathavan A, Mangaleswaran B, Ghosh S, John R.

Acta Oncol. 2019 Oct 1:1-4. doi: 10.1080/0284186X.2019.1672893. [Epub ahead of print] No abstract available.

PMID:
31573367
2.

The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.

Han SJ, Rutledge WC, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA.

Neurosurgery. 2015 Aug;77(2):248-53; discussion 253. doi: 10.1227/NEU.0000000000000766.

3.

In Reply: Survival With Glioblastoma Multiforme and the Timing of Chemoradiation.

Han SJ, Butowski NA.

Neurosurgery. 2016 Feb;78(2):E315. doi: 10.1227/NEU.0000000000001078. No abstract available.

PMID:
26492432
4.

Letter: Survival With Glioblastoma Multiforme and the Timing of Chemoradiation.

Florman JE, Evans DL, Lu-Emerson C, Cushing D, Rughani A.

Neurosurgery. 2016 Feb;78(2):E313-4. doi: 10.1227/NEU.0000000000001077. No abstract available.

PMID:
26492431
5.

[Results of postoperative radiochemotherapy of glioblastoma multiforme].

Lövey J, Fedorcsák I, Bajcsay A, Sipos L, Mangel L, Kásler M, Bagó A.

Magy Onkol. 2013 Dec;57(4):232-9. doi: MagyOnkol.2013.57.4.232. Epub 2013 Nov 1. Hungarian.

6.

Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme.

Mañé JM, Fernández R, Muñoz A, Rubio I, Ferreiro J, López-Argumedo G, Barceló R, López-Vivanco G.

Tumori. 2004 Nov-Dec;90(6):562-6.

PMID:
15762357
7.

Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.

Graus F, Bruna J, Pardo J, Escudero D, Vilas D, Barceló I, Brell M, Pascual C, Crespo JA, Erro E, García-Romero JC, Estela J, Martino J, García-Castaño A, Mata E, Lema M, Gelabert M, Fuentes R, Pérez P, Manzano A, Aguas J, Belenguer A, Simón A, Henríquez I, Murcia M, Vivanco R, Rojas-Marcos I, Muñoz-Carmona D, Navas I, de Andrés P, Mas G, Gil M, Verger E.

Neuro Oncol. 2013 Jun;15(6):797-805. doi: 10.1093/neuonc/not013. Epub 2013 Mar 3.

8.

Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.

Daróczi B, Szántó E, Tóth J, Barzó P, Bognár L, Bakó G, Szántó J, Mózes P, Hideghéty K.

Ideggyogy Sz. 2013 Nov 30;66(11-12):391-8.

PMID:
24555238
9.

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.

BMC Cancer. 2006 Oct 18;6:247.

10.

Salvage Fractionated Stereotactic Radiotherapy with or without Chemotherapy and Immunotherapy for Recurrent Glioblastoma Multiforme: A Single Institution Experience.

Hasan S, Chen E, Lanciano R, Yang J, Hanlon A, Lamond J, Arrigo S, Ding W, Mikhail M, Ghaneie A, Brady L.

Front Oncol. 2015 May 15;5:106. doi: 10.3389/fonc.2015.00106. eCollection 2015.

11.

[Temozolomide in patients with a glioblastoma multiforme: new developments].

Bromberg JE, Postma TJ.

Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1376-8. Dutch.

PMID:
15997689
12.

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†.

Chauffert B, Feuvret L, Bonnetain F, Taillandier L, Frappaz D, Taillia H, Schott R, Honnorat J, Fabbro M, Tennevet I, Ghiringhelli F, Guillamo JS, Durando X, Castera D, Frenay M, Campello C, Dalban C, Skrzypski J, Chinot O.

Ann Oncol. 2014 Jul;25(7):1442-7. doi: 10.1093/annonc/mdu148. Epub 2014 Apr 9.

PMID:
24723487
13.

Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study.

van der Louw EJTM, Olieman JF, van den Bemt PMLA, Bromberg JEC, Oomen-de Hoop E, Neuteboom RF, Catsman-Berrevoets CE, Vincent AJPE.

Ther Adv Med Oncol. 2019 Jun 21;11:1758835919853958. doi: 10.1177/1758835919853958. eCollection 2019.

14.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
15.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
16.

A pilot study of glioblastoma multiforme in elderly patients: treatments, O-6-methylguanine-DNA methyltransferase (MGMT) methylation status and survival.

Abhinav K, Aquilina K, Gbejuade H, La M, Hopkins K, Iyer V.

Clin Neurol Neurosurg. 2013 Aug;115(8):1375-8. doi: 10.1016/j.clineuro.2012.12.023. Epub 2013 Jan 18.

PMID:
23333005
17.

Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.

Hoffermann M, Bruckmann L, Kariem Mahdy A, Asslaber M, Payer F, von Campe G.

Clin Neurol Neurosurg. 2015 Jan;128:60-9. doi: 10.1016/j.clineuro.2014.11.006. Epub 2014 Nov 15.

PMID:
25462098
18.

Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.

Batash R, Asna N, Schaffer P, Francis N, Schaffer M.

Curr Med Chem. 2017;24(27):3002-3009. doi: 10.2174/0929867324666170516123206. Review.

PMID:
28521700
19.

Therapy of glioblastoma multiforme: a cumulative experience of 10 years.

Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H.

Acta Neurochir (Wien). 1995;137(1-2):29-33.

PMID:
8748864
20.

Primary glioblastoma multiforme in younger patients: a single-institution experience.

Ulutin C, Fayda M, Aksu G, Cetinayak O, Kuzhan O, Ors F, Beyzadeoglu M.

Tumori. 2006 Sep-Oct;92(5):407-11.

PMID:
17168433

Supplemental Content

Support Center